Skip to main content
Top
Published in: Clinical and Experimental Nephrology 1/2009

01-02-2009 | Original Article

Decreased body mass index as an independent risk factor for developing chronic kidney disease

Authors: Kaori Tokashiki, Masahiko Tozawa, Chiho Iseki, Kentaro Kohagura, Kozen Kinjo, Shuichi Takishita, Kunitoshi Iseki

Published in: Clinical and Experimental Nephrology | Issue 1/2009

Login to get access

Abstract

Background

Obesity and metabolic syndrome are risk factors for the development of chronic kidney disease (CKD). Few studies have examined the effect of change in body mass index (ΔBMI) on CKD incidence in a general screening setting.

Methods

Subjects of this study were screenees that participated in the screening program of the Okinawa General Health Maintenance Association in 1993 and 2003 in Okinawa, Japan. Using identification number, birth date, sex, and other recorded identifiers, we identified 33,389 subjects among the 1993 screening participants (N = 143,948) who also participated in the 2003 screening. CKD was defined as estimated glomerular filtration rate <60 ml/min/1.73 m2, according to the modification of diet in renal disease study equation. Obesity was defined as BMI ≥ 25 kg/m2.

Results

CKD prevalence was 13.8% in 1993 and 22.4% in 2003. The incidence of developing CKD in 10 years was 15.5%. The effect of ΔBMI on CKD incidence was evaluated after considering other confounding factors such as age, sex, blood pressure, BMI, fasting plasma glucose, and proteinuria. Median ΔBMI was 1.0%. The adjusted odds ratio (95% CI) for the effect of ΔBMI on CKD incidence was 1.111 (1.026–1.204, < 0.01; entire study population), 1.271 (1.116–1.448, P = 0.0030; men), and 1.030 (0.931–1.139, NS; women), when ΔBMI ≥ 1% was taken as a reference. ΔBMI was an independent predictor of CKD incidence.

Conclusions

The present results suggest that there was an inverse relationship between ΔBMI and CKD incidence among screened subjects. The reasons for this observation are not clear, but careful follow-up for ΔBMI is necessary, particularly in obese men with proteinuria.
Literature
2.
go back to reference US Renal Data System. USRDS 2006 annual data report: atlas of end-stage renal disease in the United States. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2006. US Renal Data System. USRDS 2006 annual data report: atlas of end-stage renal disease in the United States. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2006.
3.
go back to reference Ogden CL, Carroll MD. Flegal KM: epidemiologic trends in overweight and obesity. Endocrinol Metab Clin North Am. 2003;32:741–60.CrossRefPubMed Ogden CL, Carroll MD. Flegal KM: epidemiologic trends in overweight and obesity. Endocrinol Metab Clin North Am. 2003;32:741–60.CrossRefPubMed
4.
go back to reference Iseki K, Kohagura K, Iseki C, et al. Changes in demographics and the prevalence of chronic kidney disease in Okinawa, Japan (1993 to 2003). Hypertens Res. 2007;30:55–62.CrossRefPubMed Iseki K, Kohagura K, Iseki C, et al. Changes in demographics and the prevalence of chronic kidney disease in Okinawa, Japan (1993 to 2003). Hypertens Res. 2007;30:55–62.CrossRefPubMed
5.
go back to reference Iseki K, Ikemiya Y, Kinjo K, et al. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int. 2004;65:1870–6.CrossRefPubMed Iseki K, Ikemiya Y, Kinjo K, et al. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int. 2004;65:1870–6.CrossRefPubMed
6.
go back to reference Hsu CY, McCulloch CE, Iribarren C, Darbinian J. Go AS: body mass index and risk for end-stage renal disease. Ann Int Med. 2006;144:21–8.CrossRefPubMed Hsu CY, McCulloch CE, Iribarren C, Darbinian J. Go AS: body mass index and risk for end-stage renal disease. Ann Int Med. 2006;144:21–8.CrossRefPubMed
8.
go back to reference Krikken JA, Lely AT, Bakker SJ. Navis G: the effect of a shift in sodium intake on renal hemodynamics is determined by body mass index in healthy young men. Kidney Int. 2007;71:260–5.CrossRefPubMed Krikken JA, Lely AT, Bakker SJ. Navis G: the effect of a shift in sodium intake on renal hemodynamics is determined by body mass index in healthy young men. Kidney Int. 2007;71:260–5.CrossRefPubMed
9.
go back to reference Fox CS, Larson MG, Leip EP, et al. Predictors of new-onset kidney disease in a community-based population. JAMA. 2004;291:844–50.CrossRefPubMed Fox CS, Larson MG, Leip EP, et al. Predictors of new-onset kidney disease in a community-based population. JAMA. 2004;291:844–50.CrossRefPubMed
10.
go back to reference Chen J, Muntner P, Hamm LL, et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med. 2004;140:167–74.CrossRefPubMed Chen J, Muntner P, Hamm LL, et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med. 2004;140:167–74.CrossRefPubMed
11.
go back to reference Stengel B, Tarver-Carr ME, Powe NR, Eberhardt MS. Brancati FL: lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiology. 2003;14:479–87.PubMed Stengel B, Tarver-Carr ME, Powe NR, Eberhardt MS. Brancati FL: lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiology. 2003;14:479–87.PubMed
12.
go back to reference Metcalf P, Baker J, Scott A, et al. Albuminuria in people at least 40 years old: effect of obesity, hypertension, and hyperlipidemia. Clin Chem. 1992;38:1802–8.PubMed Metcalf P, Baker J, Scott A, et al. Albuminuria in people at least 40 years old: effect of obesity, hypertension, and hyperlipidemia. Clin Chem. 1992;38:1802–8.PubMed
13.
go back to reference Kambham N, Markowitz GS, Valeri AM, et al. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 2001;59:1498–509.CrossRefPubMed Kambham N, Markowitz GS, Valeri AM, et al. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 2001;59:1498–509.CrossRefPubMed
14.
go back to reference Tanaka H, Shiohira Y, Uezu Y, et al. Metabolic syndrome and chronic kidney disease in Okinawa, Japan. Kidney Int. 2006;69:369–74.CrossRefPubMed Tanaka H, Shiohira Y, Uezu Y, et al. Metabolic syndrome and chronic kidney disease in Okinawa, Japan. Kidney Int. 2006;69:369–74.CrossRefPubMed
15.
go back to reference Kurella M, Lo JC. Chertow GM: metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol. 2005;16:2134–40.CrossRefPubMed Kurella M, Lo JC. Chertow GM: metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol. 2005;16:2134–40.CrossRefPubMed
16.
go back to reference Praga M, Hernandez E, Andres A, et al. Effects of body weight loss and captopril treatment on proteinuria associated with obesity. Nephron. 1995;70:35–41.CrossRefPubMed Praga M, Hernandez E, Andres A, et al. Effects of body weight loss and captopril treatment on proteinuria associated with obesity. Nephron. 1995;70:35–41.CrossRefPubMed
17.
go back to reference Tozawa M, Iseki K, Iseki C, Oshiro S, Ikemiya Y, Takishita S. Influence of smoking and obesity on the development of proteinuria. Kidney Int. 2002;62:956–62.CrossRefPubMed Tozawa M, Iseki K, Iseki C, Oshiro S, Ikemiya Y, Takishita S. Influence of smoking and obesity on the development of proteinuria. Kidney Int. 2002;62:956–62.CrossRefPubMed
18.
go back to reference Domrongkitchaiporn S, Sritara P, Kitiyakara C, et al. Risk factors for development of decreased kidney function in a Southeast Asian population: a 12-year cohort study. J Am Soc Nephrol. 2005;16:791–9.CrossRefPubMed Domrongkitchaiporn S, Sritara P, Kitiyakara C, et al. Risk factors for development of decreased kidney function in a Southeast Asian population: a 12-year cohort study. J Am Soc Nephrol. 2005;16:791–9.CrossRefPubMed
19.
go back to reference Kopple JD, Greene T, Chumlea WC, et al. Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney Int. 2000;57:1688–703.CrossRefPubMed Kopple JD, Greene T, Chumlea WC, et al. Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney Int. 2000;57:1688–703.CrossRefPubMed
20.
go back to reference National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease. Evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S170–212.CrossRef National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease. Evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S170–212.CrossRef
21.
go back to reference Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247–54.CrossRefPubMed Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247–54.CrossRefPubMed
22.
go back to reference Ejerblad E, Fored CM, Lindblad P, et al. Obesity and risk of chronic renal failure. J Am Soc Nephrol. 2006;17:1695–702.CrossRefPubMed Ejerblad E, Fored CM, Lindblad P, et al. Obesity and risk of chronic renal failure. J Am Soc Nephrol. 2006;17:1695–702.CrossRefPubMed
23.
24.
go back to reference Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function—measure and estimated Glomerular filtration rate. N Engl J Med. 2006;354:2473–83.CrossRefPubMed Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function—measure and estimated Glomerular filtration rate. N Engl J Med. 2006;354:2473–83.CrossRefPubMed
25.
go back to reference Elsayed EF, Sarnak MJ, Tighiouart H, et al. Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis. 2008;52:29–38.CrossRefPubMedPubMedCentral Elsayed EF, Sarnak MJ, Tighiouart H, et al. Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis. 2008;52:29–38.CrossRefPubMedPubMedCentral
26.
go back to reference Imai E, Horio M, Nitta K, et al. Estimation of glomerular filtration rate by the MDRD equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol. 2007;11:41–50.CrossRefPubMed Imai E, Horio M, Nitta K, et al. Estimation of glomerular filtration rate by the MDRD equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol. 2007;11:41–50.CrossRefPubMed
28.
go back to reference Hemmelgarn BR, Zhang J, Manns BJ, et al. Progression of kidney dysfunction in the community-dwelling elderly. J Am Soc Nephrol. 2006;69:2155–61. Hemmelgarn BR, Zhang J, Manns BJ, et al. Progression of kidney dysfunction in the community-dwelling elderly. J Am Soc Nephrol. 2006;69:2155–61.
29.
go back to reference Eriksen BO. Ingebretsen OC: the progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int. 2006;69:375–82.CrossRefPubMed Eriksen BO. Ingebretsen OC: the progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int. 2006;69:375–82.CrossRefPubMed
30.
go back to reference Iseki K, Iseki C, Ikemiya Y, Kinjo K, Takishita S. Risk of developing low GFR or elevated serum creatinine in a screened cohort in Okinawa, Japan. Hypertens Res. 2007;30:167–74.CrossRefPubMed Iseki K, Iseki C, Ikemiya Y, Kinjo K, Takishita S. Risk of developing low GFR or elevated serum creatinine in a screened cohort in Okinawa, Japan. Hypertens Res. 2007;30:167–74.CrossRefPubMed
Metadata
Title
Decreased body mass index as an independent risk factor for developing chronic kidney disease
Authors
Kaori Tokashiki
Masahiko Tozawa
Chiho Iseki
Kentaro Kohagura
Kozen Kinjo
Shuichi Takishita
Kunitoshi Iseki
Publication date
01-02-2009
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 1/2009
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-008-0085-y

Other articles of this Issue 1/2009

Clinical and Experimental Nephrology 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine